Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Melanoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 9 Breast Neoplasms 6 Neoplasms 4 Colorectal Neoplasms 3 Multiple Myeloma 2 Insulin Resistance 2 Cardiotoxicity 2 Weight Loss 1 Warts 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Limb-girdle muscular dystrophy, type 2C 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Fatigue 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Cognitive Dysfunction 1 Carcinoma, Hepatocellular 1 Cachexia 1 Brenner Tumor 1 Bone Metastases 1 Body Weight 1

Interventions

Ipilimumab 96 pembrolizumab 81 Nivolumab 79 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Interferon alpha-2 12 spartalizumab 10 cobimetinib 10 atezolizumab 10 Radiotherapy 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06694571 2026-04-03

STARS

University of Utah

Phase NA Completed

38 enrolled 9 charts

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡